These systems work together to maintain bone density, nerve and muscle function, and kidney health. When this regulation fails, conditions including osteoporosis, hypercalcemia, hypocalcemia, vitamin D deficiency, and hyperparathyroidism develop, requiring specialist assessment from a bone health specialist in Dubai.
Bone and Mineral Health in Dubai: Expert Specialist Care by Dr. Ali Aldibbiat
20+ Years Clinical Experience | FRCP (London) | FRCP (Edinburgh) | PhD Researcher | FACE | Associate Professor | Jumeirah, Dubai
Bone and mineral health encompasses some of the most complex and most commonly missed conditions in endocrinology. Osteoporosis progresses silently for decades before a fracture announces its presence. Vitamin D deficiency is near-universal in Dubai despite abundant sunshine. Primary hyperparathyroidism causes hypercalcemia, kidney stones, and progressive bone loss while remaining undiagnosed in many patients for years. As a bone health specialist in Dubai, Dr. Ali Aldibbiat provides expert diagnosis and management of the full spectrum of metabolic bone and mineral disorders at his bone health specialist Dubai clinic in Jumeirah.
What Is Bone and Mineral Health?
Bone and mineral health refers to the integrity of the skeleton and the hormonal systems that regulate calcium, phosphate, vitamin D, and parathyroid hormone.
A living cycle of formation and resorption
The skeleton is not inert structural material. It is a dynamic organ, continuously remodeled by osteoblasts (bone-forming cells) and osteoclasts (bone-resorbing cells) under the influence of parathyroid hormone, vitamin D, oestrogen, testosterone, cortisol, thyroid hormone, and growth hormone.
Cells responsible for producing new bone tissue.
Cells responsible for breaking down older bone tissue.
Each of these hormones forms part of Dr. Ali Aldibbiat's specialist practice as a bone health specialist in Dubai. Bone mineral disorders do not exist in isolation from the broader endocrine system: they are expressions of hormonal imbalance.
Local lifestyle factors influence bone health
In Dubai and the UAE, bone and mineral health challenges are shaped by the local environment and population. Vitamin D deficiency is extremely prevalent because indoor lifestyles, sun avoidance, and cultural dress limit cutaneous vitamin D synthesis despite year-round sunshine.
Secondary hyperparathyroidism from vitamin D deficiency is correspondingly common. Postmenopausal osteoporosis, steroid-induced bone loss, and calcium metabolism disorders are regularly seen in clinical practice at Dr. Ali Aldibbiat's bone health specialist clinic in Dubai.
Bone and Mineral Health Conditions Treated in Dubai
Dr. Ali Aldibbiat's bone health specialist practice in Dubai covers the full spectrum of metabolic bone and mineral disorders. Each condition requires a distinct diagnostic approach and personalized treatment plan.
Osteoporosis
Reduced bone mineral density leading to increased fragility and fracture risk.
Underlying drivers
Driven by postmenopausal estrogen deficiency, steroid use, vitamin D deficiency, hyperparathyroidism, hypogonadism, and other secondary causes.
Treatment approach
Treatment ranges from vitamin D and calcium optimisation through bisphosphonates, denosumab, and anabolic therapy (teriparatide, romosozumab) based on FRAX fracture risk.
Vitamin D Deficiency
Extremely prevalent in Dubai and the UAE.
Clinical effects
Vitamin D deficiency causes secondary hyperparathyroidism, impaired calcium absorption, muscle weakness, bone pain, and accelerated bone loss. Severe deficiency causes osteomalacia (soft bones with bone pain and fracture risk).
Treatment pathway
Treatment: vitamin D3 loading doses followed by maintenance supplementation. Vitamin D correction is a foundational step in bone health specialist care in Dubai.
Primary Hyperparathyroidism
A benign parathyroid adenoma secretes excess PTH autonomously, causing hypercalcemia, kidney stones, bone loss, fatigue, and depression.
How it is detected
Often discovered incidentally on routine blood tests as elevated calcium. Mild cases are monitored with bone density and renal assessment.
Management
Significant cases require parathyroidectomy, which is curative. Dr. Ali Aldibbiat manages the full assessment and surgical referral pathway as a bone health specialist in Dubai.
Severe hypercalcemia is a medical emergency.
Hypercalcemia
Elevated serum calcium can arise from several distinct causes and requires a complete differential workup.
Potential causes
Primary hyperparathyroidism (most common), malignancy (myeloma, bone metastases, PTHrP-secreting tumors), vitamin D toxicity, granulomatous disease (sarcoidosis), or immobilization.
Specialist assessment
As a bone health specialist in Dubai, Dr. Ali Aldibbiat performs the complete hypercalcemia differential workup at the first consultation.
Hypocalcaemia
Low serum calcium may result from hypoparathyroidism, vitamin D deficiency, malabsorption, or renal failure.
Common causes
Low serum calcium from hypoparathyroidism (post-surgical or autoimmune), vitamin D deficiency, malabsorption, or renal failure.
Long-term management
Chronic hypocalcemia from hypoparathyroidism requires long-term calcium and active vitamin D supplementation with careful monitoring to avoid kidney damage from overcorrection.
Osteomalacia
Bone softening from severe vitamin D deficiency or phosphate wasting disorders.
Symptoms and distinction
Causes diffuse bone pain, tenderness, muscle weakness, and, in severe cases, fractures (pseudofractures on imaging). It is distinct from osteoporosis in its cause and presentation.
Cause-specific treatment
Responds to vitamin D replacement in deficiency-driven cases. Phosphate wasting disorders, including X-linked hypophosphatemia and tumor-induced osteomalacia, require specific diagnosis and different treatment.
Paget's Disease of Bone
A disorder of localized excessive bone remodeling causing enlarged, deformed, and structurally weakened bones.
Clinical presentation
Often asymptomatic but can cause bone pain, deformity, nerve compression, and very rarely malignant transformation.
Treatment response
Treatment with bisphosphonates (zoledronic acid) produces sustained remission in most patients.
Symptoms of Bone and Mineral Disorders: When to See a Bone Health Specialist in Dubai
Many bone and mineral disorders are silent until a complication occurs. Others produce symptoms that are non-specific and easily missed or attributed to other causes. The following patterns warrant assessment by a bone health specialist in Dubai.
Fragility Fracture
A fracture from a minor fall or bump that a healthy skeleton would not sustain.
Wrist, spine, and hip are the most common sites. Any fragility fracture is the most urgent indication for a bone health specialist in Dubai assessment. It signals established osteoporosis requiring prompt treatment to prevent the next fracture.
Bone Pain and Tenderness
Diffuse bone pain and tenderness may indicate osteomalacia, Paget's disease, or another underlying cause.
Diffuse bone pain and bone tenderness to pressure suggest osteomalacia (from vitamin D deficiency) or Paget's disease. Bone pain in a patient with known malignancy raises concern for bone metastases. Bone pain without obvious cause always warrants calcium, vitamin D, PTH, and alkaline phosphatase testing as a first step.
Kidney Stones
Recurrent calcium stones may reveal a parathyroid or calcium metabolism disorder.
Recurrent calcium oxalate or calcium phosphate kidney stones should prompt calcium and parathyroid hormone testing to exclude primary hyperparathyroidism, the most common surgically correctable cause of hypercalcemia. A bone health specialist in Dubai evaluates kidney stone patients for the full range of calcium metabolism disorders.
Muscle Weakness, Cramps, and Tingling
Weakness, cramps, tingling, and difficulty rising may reflect vitamin D deficiency, hypocalcemia, or steroid-related disease.
Muscle weakness and bone pain together suggest vitamin D deficiency with secondary hyperparathyroidism. Muscle cramps, perioral tingling, and carpopedal spasm suggest hypocalcemia from hypoparathyroidism or severe vitamin D deficiency. Proximal muscle weakness (difficulty rising from a chair) in a patient on long-term steroids raises concern for both steroid myopathy and steroid-induced bone loss.
Weakness + bone pain Vitamin D deficiency with secondary hyperparathyroidism
Cramps + tingling Possible hypocalcemia
Difficulty rising Steroid myopathy or steroid-induced bone loss
Fatigue, Nausea, and Confusion
Unexplained fatigue with elevated calcium requires urgent specialist assessment.
Hypercalcemia from primary hyperparathyroidism or malignancy causes a characteristic symptom complex: fatigue and low energy, nausea and constipation, polyuria, polydipsia, and, at higher levels, confusion and drowsiness. Any patient with unexplained fatigue and elevated calcium on a routine blood test requires urgent bone health specialist assessment in Dubai.
Height Loss and Back Pain
Progressive height loss and thoracic back pain may indicate vertebral compression fractures from osteoporosis.
Progressive loss of height and thoracic back pain in a postmenopausal woman or an older man on steroids suggests vertebral compression fractures from osteoporosis. This is a late presentation of advanced disease. A bone health specialist in Dubai confirms the diagnosis with spine imaging and DEXA, establishes the secondary cause, and initiates appropriate treatment.
How Dr. Ali diagnoses bone and mineral conditions in Dubai
Accurate diagnosis requires a structured biochemical approach combined with targeted imaging. The correct investigation sequence helps prevent misdiagnosis and identifies reversible causes before treatment begins.
First
Explore the four core investigation stages
Bone Profile: Calcium, Phosphate and Alkaline Phosphatase
The bone profile is the starting point for investigating bone and mineral disorders. Results are interpreted together rather than as isolated values, allowing characteristic biochemical patterns to guide the next investigation.
Elevated calcium with elevated or inappropriately normal PTH suggests primary hyperparathyroidism.
Raised alkaline phosphatase with normal calcium and phosphate may suggest Paget’s disease or osteomalacia.
Low calcium with elevated PTH can point toward vitamin D deficiency or other calcium-regulation disorders.
Vitamin D and Parathyroid Hormone Assessment
Serum 25-hydroxyvitamin D and PTH are assessed together to distinguish vitamin D deficiency, secondary hyperparathyroidism and primary hyperparathyroidism.
A 25-hydroxyvitamin D result below 50 nmol/L supports a diagnosis of vitamin D deficiency.
Elevated PTH with low vitamin D commonly indicates secondary hyperparathyroidism.
Elevated calcium and PTH despite adequate vitamin D raises suspicion of primary hyperparathyroidism.
DEXA Scan and FRAX Fracture-Risk Calculation
DEXA measures bone mineral density at clinically important skeletal sites, while FRAX combines bone density with clinical risk factors to estimate ten-year fracture probability.
DEXA evaluates bone mineral density at the hip and lumbar spine and reports results using T-scores.
FRAX estimates ten-year major osteoporotic and hip-fracture probability.
Together, the results guide whether medication is needed and how intensive treatment should be.
Targeted Imaging for Parathyroid and Bone Disorders
Imaging is selected according to the suspected diagnosis. It is used to localise abnormal parathyroid tissue, identify silent fractures, map Paget’s disease and assess renal complications of hypercalcaemia.
Sestamibi scanning and parathyroid ultrasound help localise adenomas before surgery.
Spine X-ray or vertebral fracture assessment can reveal asymptomatic vertebral fractures.
Nuclear bone scans and renal ultrasound assess Paget’s disease distribution, stones and nephrocalcinosis.
Screen the Biochemistry
Begin with calcium, phosphate, alkaline phosphatase, vitamin D and PTH according to the clinical presentation.
Recognise the Pattern
Interpret results together to distinguish deficiency, secondary causes and autonomous parathyroid disease.
Measure Bone Risk
Use DEXA and FRAX where appropriate to quantify bone loss and future fracture probability.
Target the Imaging
Select imaging only when it answers a defined clinical question or supports treatment planning.
This content is intended for general education and does not replace an individual medical consultation. Test selection and interpretation must be based on the patient’s complete clinical circumstances.
Bone health specialist care in Dubai
Precision treatment for bone and mineral health.
Bone and mineral health treatment requires matching each intervention precisely to the underlying diagnosis. Dr. Ali Aldibbiat’s approach is diagnosis-driven, individualised and never generic.
Interactive clinical pathway
Explore Dr. Ali’s treatment approach
Vitamin D Replacement & Calcium Optimisation
Vitamin D and calcium optimisation are foundational to almost every bone and mineral health plan. Severe deficiency may require loading doses of vitamin D3, followed by maintenance supplementation adjusted to reach and sustain target levels.
Bisphosphonates, Denosumab & Anabolic Agents
Alendronate, risedronate and zoledronic acid can stabilise bone density and reduce osteoporotic fracture risk. Denosumab may be selected for patients with kidney disease or bisphosphonate intolerance, while anabolic therapy is reserved for severe disease.
Surgical Referral for Primary Hyperparathyroidism
Parathyroidectomy is the definitive treatment for eligible patients with primary hyperparathyroidism, including those with significant hypercalcaemia, kidney stones, bone loss or age below 50.
Long-Term Monitoring & Surveillance
Structured surveillance helps confirm treatment response, identify complications and determine whether therapy should continue, change or pause. Monitoring intervals are matched to the diagnosis and the selected treatment.
Monitoring is part of the treatment—not an afterthought.
Long-term follow-up is structured around clinically meaningful checkpoints, allowing treatment to remain effective, appropriate and responsive as risk changes over time.
Bone Mineral Density
DEXA commonly rechecked two years after pharmacological treatment begins.
Vitamin D, Calcium & PTH
Annual biochemical review where deficiency or hyperparathyroidism requires surveillance.
Paget’s Disease Response
Alkaline phosphatase monitored six-monthly during treatment to confirm remission.
Bisphosphonate Review
A drug holiday may be considered after five years in suitable lower-risk patients.
This educational content does not replace an individual medical consultation. Treatment suitability and monitoring intervals must be determined by a qualified clinician.
Bone and mineral health treatment in Dubai.
Every intervention must match the underlying diagnosis. Vitamin D, calcium, anti-resorptive therapy, anabolic agents and surgical referral each have precise indications. Dr. Ali Aldibbiat’s approach is diagnosis-driven and never generic.
A structured journey from correction to surveillance.
Vitamin D Replacement and Calcium Optimisation
Vitamin D and calcium optimisation are foundational to almost every bone and mineral treatment plan. Severe deficiency may require a loading course of vitamin D3 followed by maintenance treatment.
Vitamin D3 loading doses may be used when deficiency is severe.
Calcium intake is optimised through diet before supplements are considered.
Correction may improve secondary hyperparathyroidism, muscle weakness and bone pain.
Bisphosphonates, Denosumab and Anabolic Agents
Medication is selected according to fracture risk, kidney function, previous fractures, treatment tolerance and the severity of osteoporosis.
Alendronate, risedronate and zoledronic acid reduce osteoporotic fracture risk.
Denosumab may be selected where kidney disease or bisphosphonate intolerance is relevant.
Teriparatide or romosozumab may be used for severe osteoporosis or fractures despite therapy.
Surgical Referral for Primary Hyperparathyroidism
Parathyroidectomy is curative for eligible patients with primary hyperparathyroidism, particularly where hypercalcaemia, kidney stones, bone loss or younger age are present.
Pre-operative workup includes parathyroid localisation and bone density assessment.
Renal function and 24-hour urine calcium are reviewed before surgery.
Post-operative monitoring includes calcium and vitamin D surveillance.
Long-Term Monitoring and Surveillance
Structured surveillance confirms treatment response, identifies complications and determines whether therapy should continue, change or pause.
DEXA is commonly repeated two years after pharmacological treatment begins.
Vitamin D, calcium and PTH may be reviewed annually where indicated.
Paget’s disease response and bisphosphonate duration are reviewed at defined intervals.
Treatment continues beyond the prescription.
Bone health care depends on clinically meaningful checkpoints. Monitoring helps verify response, detect complications and keep treatment aligned with the patient’s changing risk.
Bone Mineral Density
DEXA commonly repeated after pharmacological therapy begins.
Vitamin D, Calcium and PTH
Biochemical surveillance where deficiency or hyperparathyroidism is present.
Paget’s Disease Response
Alkaline phosphatase may be monitored to confirm remission.
Bisphosphonate Review
A drug holiday may be considered in suitable lower-risk patients.
This content is for general education and does not replace an individual medical consultation. Treatment and monitoring must be personalised by a qualified clinician.
Why choose Dr. Ali Aldibbiat in Dubai?
Dr. Ali Aldibbiat combines more than 20 years of specialist clinical experience with dual FRCP fellowships and PhD research in metabolic bone and hormonal science. This background supports precise management across the full spectrum of bone and mineral disorders.
Diagnostic precision
Specialist care
Dubai requires a different clinical lens.
Environmental, lifestyle and population factors influence how bone disease presents in Dubai. A specialist assessment must account for these factors from the first consultation.
Widespread Vitamin D Deficiency
Despite year-round sunshine, indoor living, heat, cultural dress and routine sun avoidance contribute to suboptimal vitamin D levels.
Secondary Hyperparathyroidism
Vitamin D deficiency may drive elevated PTH and create the appearance of primary bone disease unless biochemical causes are assessed correctly.
Under-Recognised Hyperparathyroidism
Slightly elevated calcium may be dismissed without investigating PTH, renal complications, bone loss or the possibility of surgical disease.
Steroid-Induced Bone Loss
Long-term corticosteroid exposure is common among patients with inflammatory and autoimmune disease and requires proactive bone protection.
The clinically significant difference.
Bone health treatment is incomplete when medication is prescribed before secondary causes, calcium metabolism and fracture patterns are properly investigated.
Bisphosphonate Prescribed Without a Secondary Cause Workup
Osteoporosis medication should not begin before evaluating thyroid disease, hyperparathyroidism, celiac disease, hypogonadism and other reversible contributors to bone loss.
Slightly Elevated Calcium Without Parathyroid Investigation
Mild hypercalcemia may represent primary hyperparathyroidism. Correct assessment requires PTH interpretation, vitamin D status, renal evaluation and assessment of skeletal complications.
Vertebral Fractures Without Specialist Assessment
Vertebral fractures may indicate severe osteoporosis, secondary bone disease or the need for anabolic therapy rather than routine treatment with a standard anti-resorptive agent.
A complete approach to bone and mineral health.
Dr. Ali’s practice connects biochemical investigation, fracture-risk assessment, calcium metabolism and endocrine diagnosis before selecting the most appropriate intervention.
Complete Secondary Cause Workup
Thyroid disease, hyperparathyroidism, celiac disease, hypogonadism and other reversible contributors are assessed before treatment.
Complete Calcium Metabolism Expertise
Care spans vitamin D deficiency, osteomalacia, hypercalcemia, hypocalcemia, hypoparathyroidism and primary hyperparathyroidism.
Medical and Surgical Pathway Coordination
Patients requiring parathyroidectomy receive structured pre-operative assessment and post-operative calcium and vitamin D monitoring.
Why indoor living changes everything.
Dubai’s year-round sunshine creates a misleading impression that vitamin D deficiency should be uncommon. In reality, intense heat encourages an indoor lifestyle, cultural dress reduces skin exposure and sun avoidance is routine. Vitamin D assessment is therefore a mandatory first step in Dr. Ali’s bone health consultation rather than a secondary consideration.
Bone health specialist near you in Dubai.
Dr. Ali Aldibbiat’s clinic at 109 Century Plaza, Jumeirah Beach Road, Jumeirah 1 welcomes patients from across Dubai, Sharjah, Abu Dhabi and the wider UAE.
Clinic
Serving patients across Dubai and the UAE.
The clinic is conveniently located in Jumeirah 1 and serves patients travelling from central Dubai, coastal communities, northern Dubai, Sharjah and Abu Dhabi.
- Jumeirah
- Downtown Dubai
- DIFC
- Dubai Marina
- Deira
- Bur Dubai
- JBR
- Al Quoz
- Mirdif
- Sharjah
- Abu Dhabi
Find focused bone, mineral and endocrine expertise in Dubai.
Specialist care focused on lasting bone health.
Expert care for metabolic bone disease, calcium metabolism and osteoporosis. No referral is required to request an appointment.
20+ years of specialist expertiseAppointment
Explore the conditions connected to bone health.
Bone health is influenced by metabolic, adrenal and pituitary conditions. These dedicated pages explain the diagnoses, hormonal mechanisms and treatment pathways that may contribute to secondary bone loss.
Osteoporosis
A complete condition guide covering DEXA diagnosis, FRAX fracture-risk assessment and pharmacological treatment for osteoporosis in Dubai.
Metabolic Disorders
Metabolic syndrome, dyslipidemia and fatty liver may influence bone health through insulin resistance, chronic inflammation and secondary hormonal effects.
Adrenal and Pituitary Disorders
Hyperprolactinemia, Cushing syndrome and pituitary disease may cause secondary bone loss through gonadal hormone suppression, cortisol excess and growth hormone deficiency.
Frequently Asked Questions: Bone Health Specialist Dubai
A bone health specialist in Dubai treats the full spectrum of metabolic bone and mineral disorders: osteoporosis (reduced bone density and fracture risk), osteomalacia (bone softening from vitamin D deficiency), primary hyperparathyroidism (excess PTH causing hypercalcemia and bone loss), vitamin D deficiency, hypocalcemia, Paget’s disease of bone, and secondary bone loss from hormonal causes including steroid use, hypogonadism, hyperthyroidism, and pituitary disease. Dr. Ali Aldibbiat provides bone health specialist Dubai care covering all of these conditions at his Jumeirah clinic.
Despite abundant sunshine, vitamin D deficiency is extremely prevalent in Dubai and the UAE because the intense heat drives an indoor lifestyle, many residents avoid direct sun exposure for cultural or aesthetic reasons, and cultural dress significantly limits skin surface area exposed to sunlight. This means cutaneous vitamin D synthesis is minimal for a large proportion of Dubai’s population. As a bone health specialist in Dubai, Dr. Ali Aldibbiat tests vitamin D in every patient presenting with bone, muscle, or fatigue symptoms and corrects deficiency as a foundational step in all bone health treatment.
Primary hyperparathyroidism is a condition where a benign parathyroid adenoma produces excess parathyroid hormone autonomously, raising blood calcium (hypercalcemia). It is often found incidentally on routine blood tests as a mildly elevated calcium. Symptoms include fatigue, kidney stones, bone loss, constipation, and, in severe cases, confusion. Diagnosis requires elevated or inappropriately normal PTH alongside elevated calcium. Parathyroid localization with sestamibi scan and ultrasound confirms the adenoma before surgical referral. Dr. Ali Aldibbiat performs this full workup as a bone health specialist in Dubai.
Osteoporosis is reduced bone mineral density from net bone loss, where the remaining bone is structurally normal but less dense. Osteomalacia is inadequate mineralization of bone from severe vitamin D deficiency, where bone matrix is laid down but not properly hardened with calcium and phosphate. Osteomalacia causes diffuse bone pain and tenderness that osteoporosis does not. Both can occur simultaneously. Distinguishing them requires vitamin D level testing alongside DEXA scanning. A bone health specialist in Dubai correctly identifies which condition is driving symptoms as a bone health specialist in Dubai.
See a bone health specialist in Dubai when you have had a fragility fracture, your DEXA scan shows osteoporosis or osteopenia with additional risk factors, your calcium is elevated on a blood test, you have recurrent kidney stones without a clear cause, you have been on steroids for more than 3 months, you have severe vitamin D deficiency not correcting with GP-level supplementation, or you have been told you have osteoporosis but have not had a secondary cause workup. Dr. Ali Aldibbiat provides bone health specialist care at 109 Century Plaza, Jumeirah Beach Road, Jumeirah 1, Dubai.
A consultant endocrinologist is the most appropriate bone health specialist in Dubai for conditions involving calcium metabolism, vitamin D, parathyroid hormone, osteoporosis, and metabolic bone disease. Dr. Ali Aldibbiat provides bone health specialist Dubai care covering osteoporosis, hyperparathyroidism, vitamin D deficiency, hypercalcemia, and osteomalacia at 109 Century Plaza, Jumeirah Beach Road, Jumeirah 1. Searching for a bone health specialist in Dubai, a bone health specialist near me, or a bone density specialist near me? Book at /contact/book-appointment/ or call +971 58 588 2295.
Dr. Ali Aldibbiat’s Endocrinology Clinic in Dubai, UAE
Dr. Ali Aldibbiat runs an endocrinology clinic at 109 Century Plaza, Jumeirah Beach Road, Jumeirah 1, Dubai, UAE. He also sees patients at Mediclinic City Hospital, Dubai. Patients from across Dubai, Abu Dhabi, Sharjah, and the wider UAE and Gulf region travel to his Jumeirah clinic for specialist endocrine and metabolic care. If you are searching for the best endocrinologist near me in Dubai, no referral is required; book directly at draliendo.com.

